← Evidence map

ArticleFrontiers in oncology2023

Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics.

Frontiers Editorial OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 38130994